This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chemical group Solvay’s acquisition of Cytec approved by Brazilian antitrust regulator

( December 9, 2015, 12:05 GMT | Official Statement) -- MLex Summary: The $5.5 billion merger between chemical companies Cytec Industries of the US and Belgium-based Solvay has been approved by Brazil’s competition authority, without restrictions. Shares in Cytec trade on the New York Stock Exchange. Solvay is listed on NYSE-Euronext in Brussels and Paris. The deal was approved, with remedies, by the European Commission last week.   OJ statement follows in Portuguese....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login